{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:51:25Z","timestamp":1795085485534,"version":"4.10.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mitochondrial dysfunction is a pathological mediator of diabetic kidney disease (DKD). Our objective was to test the mitochondrially targeted agent, MitoQ, alone and in combination with first line therapy for DKD. Intervention therapies (i) vehicle (D); (ii) MitoQ (DMitoQ;0.6\u2009mg\/kg\/day); (iii) Ramipril (DRam;3\u2009mg\/kg\/day) or (iv) combination (DCoAd) were administered to male diabetic<jats:italic>db<\/jats:italic>\/<jats:italic>db<\/jats:italic>mice for 12 weeks (<jats:italic>n<\/jats:italic>\u2009=\u200911\u201313\/group). Non-diabetic (C)<jats:italic>db<\/jats:italic>\/<jats:italic>m<\/jats:italic>mice were followed concurrently. No therapy altered glycaemic control or body weight. By the study end, both monotherapies improved renal function, decreasing glomerular hyperfiltration and albuminuria. All therapies prevented tubulointerstitial collagen deposition, but glomerular mesangial expansion was unaffected. Renal cortical concentrations of ATP, ADP, AMP, cAMP, creatinine phosphate and ATP:AMP ratio were increased by diabetes and mostly decreased with therapy. A higher creatine phosphate:ATP ratio in diabetic kidney cortices, suggested a decrease in ATP consumption. Diabetes elevated glucose 6-phosphate, fructose 6-phosphate and oxidised (NAD+ and NADP+) and reduced (NADH) nicotinamide dinucleotides, which therapy decreased generally. Diabetes increased mitochondrial oxygen consumption (OCR) at complex II-IV. MitoQ further increased OCR but decreased ATP, suggesting mitochondrial uncoupling as its mechanism of action. MitoQ showed renoprotection equivalent to ramipril but no synergistic benefits of combining these agents were shown.<\/jats:p>","DOI":"10.1038\/s41598-017-15589-x","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T14:56:00Z","timestamp":1509720960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes"],"prefix":"10.1038","volume":"7","author":[{"given":"Micheal S.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole B.","family":"Flemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-8517","authenticated-orcid":false,"given":"Linda A.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia K.","family":"Fotheringham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica A.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aowen","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle J.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Harvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Briskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2284-1033","authenticated-orcid":false,"given":"Llion A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel R.","family":"Plan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-1886","authenticated-orcid":false,"given":"Mark P.","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5595-8174","authenticated-orcid":false,"given":"Josephine M.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"15589_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1681\/ASN.2012070718","volume":"24","author":"M Afkarian","year":"2013","unstructured":"Afkarian, M. et al. Kidney disease and increased mortality risk in type 2 diabetes. Journal of the American Society of Nephrology: JASN 24, 302\u2013308, https:\/\/doi.org\/10.1681\/ASN.2012070718 (2013).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"Suppl 1","key":"15589_CR2","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc12-s011","volume":"35","author":"A American Diabetes","year":"2012","unstructured":"American Diabetes, A. Standards of medical care in diabetes\u20132012. Diabetes care 35(Suppl 1), S11\u201363, https:\/\/doi.org\/10.2337\/dc12-s011 (2012).","journal-title":"Diabetes care"},{"key":"15589_CR3","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990-2010. The New England journal of medicine 370, 1514\u20131523, https:\/\/doi.org\/10.1056\/NEJMoa1310799 (2014).","journal-title":"The New England journal of medicine"},{"key":"15589_CR4","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615\u20131625 (2005).","journal-title":"Diabetes"},{"key":"15589_CR5","doi-asserted-by":"publisher","unstructured":"Forbes, J. M. & Cooper, M. E. Mechanisms of diabetic complications. Physiol Rev 93, 137\u2013188, https:\/\/doi.org\/10.1152\/physrev.00045.2011 93\/1\/137 [pii] (2013).","DOI":"10.1152\/physrev.00045.2011"},{"key":"15589_CR6","unstructured":"Newsholme, E. A. & Leech, A. R. Functional biochemistry in health and disease. (Wiley; Chichester: John Wiley [distributor], 2009)."},{"key":"15589_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1073\/pnas.77.1.447","volume":"77","author":"RS Balaban","year":"1980","unstructured":"Balaban, R. S., Mandel, L. J., Soltoff, S. P. & Storey, J. M. Coupling of active ion transport and aerobic respiratory rate in isolated renal tubules. Proceedings of the National Academy of Sciences of the United States of America 77, 447\u2013451 (1980).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"15589_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1146\/annurev.ph.48.030186.000301","volume":"48","author":"SP Soltoff","year":"1986","unstructured":"Soltoff, S. P. ATP and the regulation of renal cell function. Annual review of physiology 48, 9\u201331, https:\/\/doi.org\/10.1146\/annurev.ph.48.030186.000301 (1986).","journal-title":"Annual review of physiology"},{"key":"15589_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ebiom.2016.03.033","volume":"7","author":"S Miyamoto","year":"2016","unstructured":"Miyamoto, S. et al. Mass Spectrometry Imaging Reveals Elevated Glomerular ATP\/AMP inDiabetes\/obesity and Identifies Sphingomyelin as a Possible Mediator. EbioMedicine 7, 121\u2013134, https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.033 (2016).","journal-title":"EbioMedicine"},{"key":"15589_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cell.2008.06.016","volume":"134","author":"DJ Pagliarini","year":"2008","unstructured":"Pagliarini, D. J. et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134, 112\u2013123, https:\/\/doi.org\/10.1016\/j.cell.2008.06.016 (2008).","journal-title":"Cell"},{"key":"15589_CR11","first-page":"629","volume":"43","author":"A Korner","year":"1994","unstructured":"Korner, A., Eklof, A. C., Celsi, G. & Aperia, A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43, 629\u2013633 (1994).","journal-title":"Mechanism and functional implications. Diabetes"},{"key":"15589_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/dmrr.2370","volume":"29","author":"C Laustsen","year":"2013","unstructured":"Laustsen, C. et al. Assessment of early diabetic renal changes with hyperpolarized [1-(13) C]pyruvate. Diabetes\/metabolism research and reviews 29, 125\u2013129, https:\/\/doi.org\/10.1002\/dmrr.2370 (2013).","journal-title":"Diabetes\/metabolism research and reviews"},{"key":"15589_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1042\/CS20150838","volume":"130","author":"MT Coughlan","year":"2016","unstructured":"Coughlan, M. T. et al. Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes. Clinical science 130, 711\u2013720, https:\/\/doi.org\/10.1042\/CS20150838 (2016).","journal-title":"Clinical science"},{"key":"15589_CR14","doi-asserted-by":"publisher","first-page":"F807","DOI":"10.1152\/ajprenal.00049.2016","volume":"310","author":"S Franzen","year":"2016","unstructured":"Franzen, S., Pihl, L., Khan, N., Gustafsson, H. & Palm, F. Pronounced kidney hypoxia precedes albuminuria in type 1 diabetic mice. American journal of physiology. Renal physiology 310, F807\u2013809, https:\/\/doi.org\/10.1152\/ajprenal.00049.2016 (2016).","journal-title":"American journal of physiology. Renal physiology"},{"key":"15589_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/1440-1681.12034","volume":"40","author":"P Hansell","year":"2013","unstructured":"Hansell, P., Welch, W. J., Blantz, R. C. & Palm, F. Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension. Clinical and experimental pharmacology & physiology 40, 123\u2013137, https:\/\/doi.org\/10.1111\/1440-1681.12034 (2013).","journal-title":"Clinical and experimental pharmacology & physiology"},{"key":"15589_CR16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1440-1827.1992.tb01880.x","volume":"42","author":"K Kaneda","year":"1992","unstructured":"Kaneda, K., Sakata, N. & Takebayashi, S. Mitochondrial enlargement and basement membrane thickening of renal proximal tubules, possible initiators of microalbuminuria in non-insulin-dependent diabetics (NIDDM). Acta pathologica japonica 42, 793\u2013799 (1992).","journal-title":"Acta pathologica japonica"},{"key":"15589_CR17","doi-asserted-by":"publisher","unstructured":"Chacko, B. K. et al. Prevention of diabetic nephropathy in Ins2(+\/)(\u2212)(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem J 432, 9\u201319, doi:https:\/\/doi.org\/10.1042\/BJ20100308BJ20100308 [pii] (2010).","DOI":"10.1042\/BJ20100308BJ20100308"},{"key":"15589_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.freeradbiomed.2011.11.017","volume":"52","author":"KC Sourris","year":"2012","unstructured":"Sourris, K. C. et al. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med 52, 716\u2013723, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.11.017 (2012).","journal-title":"Free Radic Biol Med"},{"key":"15589_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ebiom.2015.04.002","volume":"2","author":"A Czajka","year":"2015","unstructured":"Czajka, A. et al. Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy. EBioMedicine 2, 499\u2013512, https:\/\/doi.org\/10.1016\/j.ebiom.2015.04.002 (2015).","journal-title":"EBioMedicine"},{"key":"15589_CR20","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.2337\/db05-1438","volume":"55","author":"C Huang","year":"2006","unstructured":"Huang, C. et al. Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways. Diabetes 55, 1826\u20131831, https:\/\/doi.org\/10.2337\/db05-1438 (2006).","journal-title":"Diabetes"},{"key":"15589_CR21","doi-asserted-by":"publisher","unstructured":"Sharma, K. et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 24, 1901\u20131912, https:\/\/doi.org\/10.1681\/ASN.2013020126 ASN.2013020126 [pii] (2013).","DOI":"10.1681\/ASN.2013020126"},{"key":"15589_CR22","doi-asserted-by":"publisher","first-page":"F367","DOI":"10.1152\/ajprenal.00571.2013","volume":"306","author":"R Che","year":"2014","unstructured":"Che, R., Yuan, Y., Huang, S. & Zhang, A. Mitochondrial dysfunction in the pathophysiology of renal diseases. American journal of physiology. Renal physiology 306, F367\u2013378, https:\/\/doi.org\/10.1152\/ajprenal.00571.2013 (2014).","journal-title":"American journal of physiology. Renal physiology"},{"key":"15589_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.tem.2016.05.002","volume":"27","author":"JM Forbes","year":"2016","unstructured":"Forbes, J. M. Mitochondria-Power Players in Kidney Function? Trends in endocrinology and metabolism: TEM 27, 441\u2013442, https:\/\/doi.org\/10.1016\/j.tem.2016.05.002 (2016).","journal-title":"Trends in endocrinology and metabolism: TEM"},{"key":"15589_CR24","doi-asserted-by":"crossref","unstructured":"Hall, A. M. & Unwin, R. J. The not so \u2018mighty chondrion\u2019: emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiol 105, p1\u201310, doi:NEP2007105001001 [pii]10.1159\/000096860 (2007).","DOI":"10.1159\/000096860"},{"key":"15589_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/ars.2012.4719","volume":"19","author":"JM Forbes","year":"2013","unstructured":"Forbes, J. M. et al. Deficiency in mitochondrial complex I activity due to Ndufs6 gene trap insertion induces renal disease. Antioxid Redox Signal 19, 331\u2013343, https:\/\/doi.org\/10.1089\/ars.2012.4719 (2013).","journal-title":"Antioxid Redox Signal"},{"key":"15589_CR26","doi-asserted-by":"publisher","unstructured":"Ma, L. et al. APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction. Journal of the American Society of Nephrology: JASN, https:\/\/doi.org\/10.1681\/ASN.2016050567 (2016).","DOI":"10.1681\/ASN.2016050567"},{"key":"15589_CR27","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1172\/JCI66218","volume":"123","author":"LL Dugan","year":"2013","unstructured":"Dugan, L. L. et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest 123, 4888\u20134899, https:\/\/doi.org\/10.1172\/JCI66218 (2013).","journal-title":"J Clin Invest"},{"key":"15589_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00125-012-2469-5","volume":"55","author":"MF Persson","year":"2012","unstructured":"Persson, M. F. et al. Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db\/db mice as a model of type 2 diabetes. Diabetologia 55, 1535\u20131543, https:\/\/doi.org\/10.1007\/s00125-012-2469-5 (2012).","journal-title":"Diabetologia"},{"key":"15589_CR29","doi-asserted-by":"publisher","first-page":"F547","DOI":"10.1152\/ajprenal.00574.2014","volume":"310","author":"Y Hou","year":"2016","unstructured":"Hou, Y. et al. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy. Am J Physiol Renal Physiol 310, F547\u2013559, https:\/\/doi.org\/10.1152\/ajprenal.00574.2014 (2016).","journal-title":"Am J Physiol Renal Physiol"},{"key":"15589_CR30","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.kint.2016.06.013","volume":"90","author":"HH Szeto","year":"2016","unstructured":"Szeto, H. H. et al. Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury. Kidney international 90, 997\u20131011, https:\/\/doi.org\/10.1016\/j.kint.2016.06.013 (2016).","journal-title":"Kidney international"},{"key":"15589_CR31","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2174\/1389450116666150727114410","volume":"17","author":"NB Flemming","year":"2016","unstructured":"Flemming, N. B., Gallo, L. A., Ward, M. S. & Forbes, J. M. Tapping into Mitochondria to Find Novel Targets for Diabetes Complications. Current drug targets 17, 1341\u20131349 (2016).","journal-title":"Current drug targets"},{"key":"15589_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","volume":"1201","author":"RA Smith","year":"2010","unstructured":"Smith, R. A. & Murphy, M. P. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 1201, 96\u2013103, https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05627.x (2010).","journal-title":"Ann N Y Acad Sci"},{"key":"15589_CR33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1172\/JCI22669","volume":"114","author":"W Kriz","year":"2004","unstructured":"Kriz, W. Adenosine and ATP: traffic regulators in the kidney. The Journal of clinical investigation 114, 611\u2013613, https:\/\/doi.org\/10.1172\/JCI22669 (2004).","journal-title":"The Journal of clinical investigation"},{"key":"15589_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1124\/jpet.112.195586","volume":"342","author":"BD Fink","year":"2012","unstructured":"Fink, B. D. et al. Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells. The Journal of pharmacology and experimental therapeutics 342, 709\u2013719, https:\/\/doi.org\/10.1124\/jpet.112.195586 (2012).","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"15589_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1124\/jpet.110.176743","volume":"336","author":"T Mitchell","year":"2011","unstructured":"Mitchell, T. et al. The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys. The Journal of pharmacology and experimental therapeutics 336, 682\u2013692, https:\/\/doi.org\/10.1124\/jpet.110.176743 (2011).","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"15589_CR36","doi-asserted-by":"publisher","first-page":"e48590","DOI":"10.1371\/journal.pone.0048590","volume":"7","author":"N Parajuli","year":"2012","unstructured":"Parajuli, N., Campbell, L. H., Marine, A., Brockbank, K. G. & Macmillan-Crow, L. A. MitoQ blunts mitochondrial and renal damage during cold preservation of porcine kidneys. PloS one 7, e48590, https:\/\/doi.org\/10.1371\/journal.pone.0048590 (2012).","journal-title":"PloS one"},{"key":"15589_CR37","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2337\/db15-0864","volume":"65","author":"MT Coughlan","year":"2016","unstructured":"Coughlan, M. T. et al. Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial Homeostasis. Diabetes 65, 1085\u20131098, https:\/\/doi.org\/10.2337\/db15-0864 (2016).","journal-title":"Diabetes"},{"key":"15589_CR38","doi-asserted-by":"crossref","unstructured":"Coughlan, M. T. et al. RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes. J Am Soc Nephrol (2009).","DOI":"10.1681\/ASN.2008050514"},{"key":"15589_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.RES.86.6.656","volume":"86","author":"A Nishiyama","year":"2000","unstructured":"Nishiyama, A., Majid, D. S., Taher, K. A., Miyatake, A. & Navar, L. G. Relation between renal interstitial ATP concentrations and autoregulation-mediated changes in renal vascular resistance. Circulation research 86, 656\u2013662 (2000).","journal-title":"Circulation research"},{"key":"15589_CR40","doi-asserted-by":"publisher","first-page":"e39430","DOI":"10.1371\/journal.pone.0039430","volume":"7","author":"BD Fink","year":"2012","unstructured":"Fink, B. D., Herlein, J. A., O\u2019Malley, Y. & Sivitz, W. I. Endothelial cell and platelet bioenergetics: effect of glucose and nutrient composition. PloS one 7, e39430, https:\/\/doi.org\/10.1371\/journal.pone.0039430 (2012).","journal-title":"PloS one"},{"key":"15589_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","volume":"129","author":"DZ Cherney","year":"2014","unstructured":"Cherney, D. Z. et al. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 129, 587\u2013597, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005081 (2014).","journal-title":"Circulation"},{"key":"15589_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4614-7411-1_2","volume":"789","author":"M Friederich-Persson","year":"2013","unstructured":"Friederich-Persson, M. et al. Increased kidney metabolism as a pathway to kidney tissue hypoxia and damage: effects of triiodothyronine and dinitrophenol in normoglycemic rats. Advances in experimental medicine and biology 789, 9\u201314, https:\/\/doi.org\/10.1007\/978-1-4614-7411-1_2 (2013).","journal-title":"Advances in experimental medicine and biology"},{"key":"15589_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner, C. et al. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. The New England journal of medicine 375, 323\u2013334, https:\/\/doi.org\/10.1056\/NEJMoa1515920 (2016).","journal-title":"The New England journal of medicine"},{"key":"15589_CR44","doi-asserted-by":"publisher","first-page":"F1269","DOI":"10.1152\/ajprenal.00543.2015","volume":"310","author":"AT Layton","year":"2016","unstructured":"Layton, A. T., Vallon, V. & Edwards, A. Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron. American journal of physiology. Renal physiology 310, F1269\u20131283, https:\/\/doi.org\/10.1152\/ajprenal.00543.2015 (2016).","journal-title":"American journal of physiology. Renal physiology"},{"key":"15589_CR45","doi-asserted-by":"publisher","first-page":"F227","DOI":"10.1152\/ajprenal.00689.2014","volume":"309","author":"J O\u2019Neill","year":"2015","unstructured":"O\u2019Neill, J. et al. Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats. American journal of physiology. Renal physiology 309, F227\u2013234, https:\/\/doi.org\/10.1152\/ajprenal.00689.2014 (2015).","journal-title":"American journal of physiology. Renal physiology"},{"key":"15589_CR46","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1152\/ajpregu.00357.2011","volume":"302","author":"SC Thomson","year":"2012","unstructured":"Thomson, S. C. et al. Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat. American journal of physiology. Regulatory, integrative and comparative physiology 302, R75\u201383, https:\/\/doi.org\/10.1152\/ajpregu.00357.2011 (2012).","journal-title":"American journal of physiology. Regulatory, integrative and comparative physiology"},{"key":"15589_CR47","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.freeradbiomed.2014.03.003","volume":"71","author":"LF Ng","year":"2014","unstructured":"Ng, L. F. et al. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease. Free radical biology & medicine 71, 390\u2013401, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.03.003 (2014).","journal-title":"Free radical biology & medicine"},{"key":"15589_CR48","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1042\/bj1281293","volume":"128","author":"PK Joseph","year":"1972","unstructured":"Joseph, P. K. & Subrahmanyam, K. Evaluation of the rate-limiting steps in the pathway of glucose metabolism in kidney cortex of normal, diabetic, cortisone-treated and growth hormone-treated rats. The Biochemical journal 128, 1293\u20131301 (1972).","journal-title":"The Biochemical journal"},{"key":"15589_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00583517","volume":"356","author":"H Bertermann","year":"1975","unstructured":"Bertermann, H., Gronow, G., Schirmer, A. & Weiss, C. Contribution of long chain fatty acids to the energy supply of the rat kidney cortex. Pflugers Archiv: European journal of physiology 356, 9\u201317 (1975).","journal-title":"Pflugers Archiv: European journal of physiology"},{"key":"15589_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF00221209","volume":"90","author":"L Garcia-Salguero","year":"1989","unstructured":"Garcia-Salguero, L. & Lupianez, J. A. Metabolic adaptation of the renal carbohydrate metabolism. III. Effects of high protein diet on the gluconeogenic and glycolytic fluxes in the proximal and distal renal tubules. Molecular and cellular biochemistry 90, 99\u2013110 (1989).","journal-title":"Molecular and cellular biochemistry"},{"key":"15589_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF01676198","volume":"18","author":"GM Lawrence","year":"1986","unstructured":"Lawrence, G. M., Jepson, M. A., Trayer, I. P. & Walker, D. G. The compartmentation of glycolytic and gluconeogenic enzymes in rat kidney and liver and its significance to renal and hepatic metabolism. The Histochemical journal 18, 45\u201353 (1986).","journal-title":"The Histochemical journal"},{"key":"15589_CR52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ki.1986.8","volume":"29","author":"BD Ross","year":"1986","unstructured":"Ross, B. D., Espinal, J. & Silva, P. Glucose metabolism in renal tubular function. Kidney international 29, 54\u201367 (1986).","journal-title":"Kidney international"},{"key":"15589_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1042\/bj1120149","volume":"112","author":"MJ Weidemann","year":"1969","unstructured":"Weidemann, M. J. & Krebs, H. A. The fuel of respiration of rat kidney cortex. Biochem J 112, 149\u2013166 (1969).","journal-title":"Biochem J"},{"key":"15589_CR54","doi-asserted-by":"publisher","first-page":"E592","DOI":"10.1152\/ajpendo.00277.2013","volume":"306","author":"JE Ostler","year":"2014","unstructured":"Ostler, J. E. et al. Effects of insulin resistance on skeletal muscle growth and exercise capacity in type 2 diabetic mouse models. American journal of physiology. Endocrinology and metabolism 306, E592\u2013605, https:\/\/doi.org\/10.1152\/ajpendo.00277.2013 (2014).","journal-title":"American journal of physiology. Endocrinology and metabolism"},{"key":"15589_CR55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5694\/mja11.11468","volume":"197","author":"DW Johnson","year":"2012","unstructured":"Johnson, D. W. et al. Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement. The Medical journal of Australia 197, 224\u2013225 (2012).","journal-title":"The Medical journal of Australia"},{"key":"15589_CR56","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa021835","volume":"348","author":"BA Perkins","year":"2003","unstructured":"Perkins, B. A. et al. Regression of microalbuminuria in type 1 diabetes. The New England journal of medicine 348, 2285\u20132293, https:\/\/doi.org\/10.1056\/NEJMoa021835 (2003).","journal-title":"The New England journal of medicine"},{"key":"15589_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2009.10.039","volume":"48","author":"S Rodriguez-Cuenca","year":"2010","unstructured":"Rodriguez-Cuenca, S. et al. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free radical biology & medicine 48, 161\u2013172, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.10.039 (2010).","journal-title":"Free radical biology & medicine"},{"key":"15589_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/srep26428","volume":"6","author":"LA Gallo","year":"2016","unstructured":"Gallo, L. A. et al. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db\/db mice. Scientific reports 6, 26428, https:\/\/doi.org\/10.1038\/srep26428 (2016).","journal-title":"Scientific reports"},{"key":"15589_CR59","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/mmi.12701","volume":"93","author":"A Chacko","year":"2014","unstructured":"Chacko, A. et al. Increased sensitivity to tryptophan bioavailability is a positive adaptation by the human strains of Chlamydia pneumoniae. Molecular microbiology 93, 797\u2013813, https:\/\/doi.org\/10.1111\/mmi.12701 (2014).","journal-title":"Molecular microbiology"},{"key":"15589_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tvjl.2015.07.031","volume":"206","author":"CE Medina-Torres","year":"2015","unstructured":"Medina-Torres, C. E., van Eps, A. W., Nielsen, L. K. & Hodson, M. P. A liquid chromatography-tandem mass spectrometry-based investigation of the lamellar interstitial metabolome in healthy horses and during experimental laminitis induction. Veterinary journal 206, 161\u2013169, https:\/\/doi.org\/10.1016\/j.tvjl.2015.07.031 (2015).","journal-title":"Veterinary journal"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15589-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15589-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15589-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T08:05:36Z","timestamp":1719561936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15589-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15589"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15589-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"assertion":[{"value":"20 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15190"}}